Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

Affiliation

Collaborators: Bissonnette J, Deschenes M, Ghali M, Tsein C, Wong F, Marquez V, Feyssa E, Wong M, Vierling J, Gonzalez S, Trotter JF, Curry M, Frederick RT, Zamor P, Sclair S, Gholam P, Brown R, Riera A, Patel V, Subramanian R, Landis C, Swales C, Reddy KR, Patel J, Sass D, Keaveny A, Vargas H, Simonetto D, Rockey D, Victor DW 3rd, Rudraraju M, Bajaj J, Satoskar R, Thuluvath P, Sigal S, Grewal P, Olsen S, Ganger D, Velez J, Rubin R, Janardhan S, Pyrsopoulos N, Befeler A, Frenette C, Hassanein T, Kumari R, Procaccini N, Kemmer N, Al-Osami A, Kalathil S, Mumtaz K, McGuire B, Desai A, Boyer T, Kurtz I, Paul S, Reddy G, Bihorac A, Sanchez A, Leventhal T, Gupta A, Bhamidimarri K, Sharma P, Lim N, Olivera M, Kahn J, Guerrero J, Mayo M, Gallegos J, Caldwell S, Paine C, Porayko M, O'Leary J, Shaikh O, Sanyal A, Korenblat K.
Author information:
(1)From the Department of Medicine, University of Toronto, Toronto
(F.W.); Orphan Therapeutics, Annandale
(S.C.P.), and Mallinckrodt Pharmaceuticals, Bedminster
(S.E., K.J.) - both in New Jersey; the Department of Medicine, Beth Israel Deaconess Medical Center, Boston
(M.P.C.); the University of Pennsylvania, Philadelphia
(K.R.R.); Piedmont Transplant Institute, Piedmont Healthcare, Atlanta
(R.A.R.); the Department of Medicine, Vanderbilt University Medical Center, Nashville
(M.K.P.); the Department of Medicine, Baylor Scott and White All Saints Medical Center, Fort Worth
(S.A.G.), and the Department of Medicine, University of Texas Southwestern Medical Center, Dallas
(M.J.M.) - both in Texas; Ohio State University, Columbus
(K.M.); the Department of Medicine, University of Minnesota, Minneapolis
(N.L.), and the Department of Medicine, Mayo Clinic, Rochester
(D.A.S.) - both in Minnesota; the Department of Medicine, University of Michigan Medical Center, Ann Arbor
(P.S.); Virginia Commonwealth University, Richmond
(A.J.S.); and Hepatology and Liver Transplantation, California Pacific Medical Center, San Francisco
(R.T.F.).

Abstract

Comment in Nat Rev Gastroenterol Hepatol. 2021 May;18(5):286. N Engl J Med. 2021 Jun 10;384(23):e90. N Engl J Med. 2021 Jun 10;384(23):e90. N Engl J Med. 2021 Jun 10;384(23):e90.